1. Home
  2. FOFO vs NCEL Comparison

FOFO vs NCEL Comparison

Compare FOFO & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

N/A

Current Price

$2.01

Market Cap

19.2M

Sector

N/A

ML Signal

N/A

Logo NewcelX Ltd. Ordinary Shares

NCEL

NewcelX Ltd. Ordinary Shares

BUY

Current Price

$2.66

Market Cap

19.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FOFO
NCEL
Founded
2017
2008
Country
Hong Kong
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
19.4M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
FOFO
NCEL
Price
$2.01
$2.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 194.4K
5.7K
Earning Date
12-04-2026
09-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.09
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$1.83
52 Week High
$14.93
$5.12

Technical Indicators

Market Signals
Indicator
FOFO
NCEL
Relative Strength Index (RSI) 45.90 40.88
Support Level $1.76 $1.95
Resistance Level $2.68 $3.32
Average True Range (ATR) 0.19 0.33
MACD -0.00 -0.01
Stochastic Oscillator 28.57 20.68

Price Performance

Historical Comparison
FOFO
NCEL

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: